Frequent travel lifestyle impacts health, productivity, and balance. Learn how professionals manage stress, sleep, and ...

Shares of Protagonist Therapeutics PTGX have gained nearly 7% over the past week. The upside came after the company announced ...

ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety ...

Johnson & Johnson’s Icotyde receives US FDA approval for first-line systemic treatment of plaque psoriasis with a targeted oral peptide: Spring House, Pennsylvania Friday, March ...

Johnson & Johnson (JNJ) on Wednesday announced that the U.S. Food and Drug Administration (FDA) approved Icotyde, a once-daily pill developed with Protagonist Therapeutics (PTGX), as a treatment for ...

Is the impact of the war in the Middle East on Irish consumers becoming any clearer? The situation is still best described as ...

Pediatric patients with moderate to severe hidradenitits suppurativa may now receive secukinumab following new FDA approval ...

A Canadian Border Services Agency detector dog made quite the catch at Toronto Pearson International Airport earlier this month.

Detector dog Dharla helped Canadian border officials confiscate more than 22 kilograms of meat from a traveller at Pearson airport.

Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has approved ICOTYDE™ (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for the treatment of ...

On Wednesday, the U.S. Food and Drug Administration (FDA) approved Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor ...

The busiest airport in Canada was recognized as the top airport in the continent for two different prestigious categories.